U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249853) titled 'Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage' on Nov. 14.
Brief Summary: The investigators propose to conduct a multicenter randomized trial to test whether cilostazol reduces the incidence of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) and improves patients' neurological prognosis, while assessing its safety.
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Aneurysmal Subarachnoid Hemorrhage
Intervention:
DRUG: Cilostazol 100 mg BID
Within 24 hours after randomization, patients will receive cilostazol 100 mg twice daily (BID) ...